{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T12:32:35Z","timestamp":1781094755372,"version":"3.54.1"},"reference-count":0,"publisher":"Informa Healthcare","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Med Res Opin"],"published-print":{"date-parts":[[2001,2,22]]},"DOI":"10.1185\/030079901750176735","type":"journal-article","created":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T18:06:28Z","timestamp":1033495588000},"page":"235-244","source":"Crossref","is-referenced-by-count":34,"title":["Human Dermal Safety Studies with Eflornithine HCl 13.9% Cream (Vaniqa\u0099), a Novel Treatment for Excessive Facial Hair"],"prefix":"10.1185","volume":"16","author":[{"given":"Janet G.","family":"Hickman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinand","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Palmisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3197","container-title":["Current Medical Research and Opinion"],"original-title":[],"deposited":{"date-parts":[[2011,8,11]],"date-time":"2011-08-11T12:56:41Z","timestamp":1313067401000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.catchword.com\/rpsv\/cgi-bin\/cgi?ini=xref&body=linker&reqdoi=10.1185\/030079901750176735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2,22]]},"references-count":0,"journal-issue":{"issue":"4"},"alternative-id":["0300-7995(20010222)16:4L.235;1-"],"URL":"https:\/\/doi.org\/10.1185\/030079901750176735","relation":{},"ISSN":["1473-4877","0300-7995"],"issn-type":[{"value":"1473-4877","type":"electronic"},{"value":"0300-7995","type":"print"}],"subject":[],"published":{"date-parts":[[2001,2,22]]}}}